Indoco Remedies Limited has informed the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited of a significant asset sale.
Nature of Disclosure: Regulatory intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Event: The company executed a Deed of Conveyance on August 27, 2026, for the sale of a plot of land.
Asset Details: The sold asset is a plot of land admeasuring approximately 2,876.08 square meters of built-up area. It is situated at Plot No.18/A of Mahal Industrial Estate, Village Mulgaon, Taluka Andheri, District Mumbai Suburban.
Transaction Details:
- Counterparty: The agreement is between Indoco Remedies Limited and Kalpataru Townships Private Limited.
- Purpose: To record the terms of the sale of the specified land.
- Total Consideration: ₹64,00,00,000 (Rupees Sixty Four Crores Only).
- Shareholding: The company confirms there is no shareholding in the entity (Kalpataru Townships Private Limited) with whom the agreement is executed.
- Related Party Status: The parties are not related to the promoter/promoter group/group companies. The transaction is not a related party transaction.
- Conflict of Interest: The company states that no potential conflict of interest is arising out of the agreement.
Financial and Operational Impact:
The company explicitly states that this sale would not have any impact on its business operations. Furthermore, it clarifies that the sale does not constitute an undertaking or substantially the whole of the undertaking of the company in terms of Section 180(1)(a) of the Companies Act, 2013.
Regulatory Reference: The disclosure is made in compliance with Regulation 30 of the SEBI LODR Regulations, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026. The required details are provided in the enclosed Annexure A.